Table 1.
General features of the enrolled cohort of CP patients
| Patient’ s features | Number (%) |
|---|---|
| Sex | |
| Male | 142/211 (67.29%) |
| Female pre-menopause | 8/211 (3.79%) |
| Female post-menopause | 61/211 (28.90%) |
| Body mass index (meaan) | 24 ± 4 |
| Diabetes | 77/211 (37%) |
| Ever alcohol drinkers | 127/211 (60%) |
| Ever smokers | 145/211 (69%) |
| Aetiology | |
| Alcoholic | 92/211 (43.60%) |
| Idiopathic | 40/211 (18.95%) |
| Hereditary | 9/211 (4.26%) |
| Obstructive | 12/211 (5.68%) |
| Other | 58/211 (27.48%) |
| Disease Severity | |
| Minor | 74/211 (35%) |
| Increased | 99/211 (47%) |
| Advanced | 32/211 (15%) |
| Marked | 6/211 (3%) |
| Pancreatic Exocrine Function | |
| Normal | 78/179 (43.57%) |
| Faecal elastase < 200 mcg/g > 100 mcg/g | 29/179 (16.20%) |
| Faecal elastase < 100 mcg/g | 72/179 (40.22%) |
| Pancreatic enzyme replacement therapy | 116/211 (54.97%) |
| Bone mineral density | |
| Normal | 76/211 (36%) |
| Osteopenia | 89/211 (42.18%) |
| Osteoporosis | 46/211 (21.80%) |
| Vitamins dosage | |
| Vitamin D (mean value; ng/ml) | 20.2 ± 12 |
| Vitamin D deficiency ( < 20 ng/ml) | 119/211 (56.39%) |
| Vitamin K (mean value; ng/ml) | 0.64 ± 0.9 |
| Vitamin K deficiency ( < 0.2 ng/ml) | 56/178 (31.46%) |
Data are presented as rate or as mean ( ± SD)